BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jochems SP, Weiser JN, Malley R, Ferreira DM. The immunological mechanisms that control pneumococcal carriage. PLoS Pathog 2017;13:e1006665. [PMID: 29267378 DOI: 10.1371/journal.ppat.1006665] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Jochems SP, de Ruiter K, Solórzano C, Voskamp A, Mitsi E, Nikolaou E, Carniel BF, Pojar S, German EL, Reiné J, Soares-Schanoski A, Hill H, Robinson R, Hyder-Wright AD, Weight CM, Durrenberger PF, Heyderman RS, Gordon SB, Smits HH, Urban BC, Rylance J, Collins AM, Wilkie MD, Lazarova L, Leong SC, Yazdanbakhsh M, Ferreira DM. Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization. J Clin Invest 2019;129:4523-38. [PMID: 31361601 DOI: 10.1172/JCI128865] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
2 Stern PL. Key steps in vaccine development. Ann Allergy Asthma Immunol 2020;125:17-27. [PMID: 32044451 DOI: 10.1016/j.anai.2020.01.025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
3 Howard LM, Grijalva CG. The central role of pneumococcal colonization in the pathogenesis and control of pneumococcal diseases. Future Microbiol 2018;13:1453-6. [PMID: 30311793 DOI: 10.2217/fmb-2018-0198] [Reference Citation Analysis]
4 Divala TH, Corbett EL, Stagg HR, Nliwasa M, Sloan DJ, French N, Fielding KL. Effect of the duration of antimicrobial exposure on the development of antimicrobial resistance (AMR) for macrolide antibiotics: protocol for a systematic review with a network meta-analysis. Syst Rev 2018;7:246. [PMID: 30580758 DOI: 10.1186/s13643-018-0917-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 O'Hara JM, Redhu NS, Cheung E, Robertson NG, Patik I, Sayed SE, Thompson CM, Herd M, Lucas KB, Conaway E, Morton CC, Farber DL, Malley R, Horwitz BH. Generation of protective pneumococcal-specific nasal resident memory CD4+ T cells via parenteral immunization. Mucosal Immunol 2020;13:172-82. [PMID: 31659300 DOI: 10.1038/s41385-019-0218-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
6 Jochems SP, Marcon F, Carniel BF, Holloway M, Mitsi E, Smith E, Gritzfeld JF, Solórzano C, Reiné J, Pojar S, Nikolaou E, German EL, Hyder-Wright A, Hill H, Hales C, de Steenhuijsen Piters WAA, Bogaert D, Adler H, Zaidi S, Connor V, Gordon SB, Rylance J, Nakaya HI, Ferreira DM. Inflammation induced by influenza virus impairs human innate immune control of pneumococcus. Nat Immunol 2018;19:1299-308. [PMID: 30374129 DOI: 10.1038/s41590-018-0231-y] [Cited by in F6Publishing: 61] [Reference Citation Analysis]
7 Huang CC, Wu PW, Lee TJ, Chen CL, Wang CH, Tsai CN, Chiu CH. Differential IL-17A response to S. pneumoniae in adenoid tissue of children with sleep disordered breathing and otitis media with effusion. Sci Rep 2019;9:19839. [PMID: 31882693 DOI: 10.1038/s41598-019-56415-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Nikolaou E, Jochems SP, Mitsi E, Pojar S, Blizard A, Reiné J, Solórzano C, Negera E, Carniel B, Soares-Schanoski A, Connor V, Adler H, Zaidi SR, Hales C, Hill H, Hyder-Wright A, Gordon SB, Rylance J, Ferreira DM. Experimental Human Challenge Defines Distinct Pneumococcal Kinetic Profiles and Mucosal Responses between Colonized and Non-Colonized Adults. mBio 2021;12:e02020-20. [PMID: 33436429 DOI: 10.1128/mBio.02020-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Nyazika TK, Law A, Swarthout TD, Sibale L, Ter Braake D, French N, Heyderman RS, Everett D, Kadioglu A, Jambo KC, Neill DR. Influenza-like illness is associated with high pneumococcal carriage density in Malawian children. J Infect 2020;81:549-56. [PMID: 32711042 DOI: 10.1016/j.jinf.2020.06.079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 de Koff EM, van Houten MA, de Heij F, Berbers GAM, Bogaert D, Sanders EAM. Salivary antibody responses to ten-valent pneumococcal conjugate vaccination following two different immunization schedules in a healthy birth cohort. Vaccine 2021:S0264-410X(21)01622-4. [PMID: 34961634 DOI: 10.1016/j.vaccine.2021.12.013] [Reference Citation Analysis]
11 Thindwa D, Wolter N, Pinsent A, Carrim M, Ojal J, Tempia S, Moyes J, Mcmorrow M, Kleynhans J, Gottberg AV, French N, Cohen C, Flasche S, Althouse B; PHIRST group. Estimating the contribution of HIV-infected adults to household pneumococcal transmission in South Africa, 2016–2018: A hidden Markov modelling study. PLoS Comput Biol 2021;17:e1009680. [DOI: 10.1371/journal.pcbi.1009680] [Reference Citation Analysis]
12 van Beek LF, Langereis JD, van den Berg van Saparoea HB, Gillard J, Jong WSP, van Opzeeland FJ, Mesman R, van Niftrik L, Joosten I, Diavatopoulos DA, Luirink J, de Jonge MI. Intranasal vaccination with protein bodies elicit strong protection against Streptococcus pneumoniae colonization. Vaccine 2021;39:6920-9. [PMID: 34696934 DOI: 10.1016/j.vaccine.2021.10.006] [Reference Citation Analysis]
13 Wantuch PL, Avci FY. Current status and future directions of invasive pneumococcal diseases and prophylactic approaches to control them. Hum Vaccin Immunother 2018;14:2303-9. [PMID: 29757699 DOI: 10.1080/21645515.2018.1470726] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
14 Gerke CE, Pulverer B, Sansonetti PJ. COVID-19 vaccination, time for a second breath? EMBO Mol Med 2022;:e15810. [PMID: 35212155 DOI: 10.15252/emmm.202215810] [Reference Citation Analysis]
15 Zangari T, Zafar MA, Lees JA, Abruzzo AR, Bee GCW, Weiser JN. Pneumococcal capsule blocks protection by immunization with conserved surface proteins. NPJ Vaccines 2021;6:155. [PMID: 34930916 DOI: 10.1038/s41541-021-00413-5] [Reference Citation Analysis]
16 Pillot A, Defontaine A, Fateh A, Lambert A, Prasanna M, Fanuel M, Pipelier M, Csaba N, Violo T, Camberlein E, Grandjean C. Site-Specific Conjugation for Fully Controlled Glycoconjugate Vaccine Preparation. Front Chem 2019;7:726. [PMID: 31737603 DOI: 10.3389/fchem.2019.00726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
17 Lavelle EC, McLachlan JB. Editorial overview: Immunomodulation: Striking the right balance: using immunomodulators to target infectious diseases, cancer, and autoimmunity. Curr Opin Pharmacol 2018;41:vii-ix. [PMID: 30139514 DOI: 10.1016/j.coph.2018.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
18 Huang CC, Wu PW, Chen CL, Wang CH, Lee TJ, Tsai CN, Chiu CH. IL-17A expression in the adenoid tissue from children with sleep disordered breathing and its association with pneumococcal carriage. Sci Rep 2018;8:16770. [PMID: 30425273 DOI: 10.1038/s41598-018-35169-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Rex JH, Fernandez Lynch H, Cohen IG, Darrow JJ, Outterson K. Designing development programs for non-traditional antibacterial agents. Nat Commun 2019;10:3416. [PMID: 31366924 DOI: 10.1038/s41467-019-11303-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
20 Trimble A, Connor V, Robinson RE, McLenaghan D, Hancock CA, Wang D, Gordon SB, Ferreira DM, Wright AD, Collins AM. Pneumococcal colonisation is an asymptomatic event in healthy adults using an experimental human colonisation model. PLoS One 2020;15:e0229558. [PMID: 32155176 DOI: 10.1371/journal.pone.0229558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
21 van Westen E, Knol MJ, Wijmenga-Monsuur AJ, Tcherniaeva I, Schouls LM, Sanders EAM, van Els CACM, Berbers GAM, Rots NY. Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine. Vaccines (Basel) 2018;6:E82. [PMID: 30544898 DOI: 10.3390/vaccines6040082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
22 Weight CM, Venturini C, Pojar S, Jochems SP, Reiné J, Nikolaou E, Solórzano C, Noursadeghi M, Brown JS, Ferreira DM, Heyderman RS. Microinvasion by Streptococcus pneumoniae induces epithelial innate immunity during colonisation at the human mucosal surface. Nat Commun 2019;10:3060. [PMID: 31311921 DOI: 10.1038/s41467-019-11005-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
23 Choi MJ, Noh JY, Cheong HJ, Kim WJ, Kim MJ, Jang YS, Lee SN, Choi EH, Lee HJ, Song JY. Spread of ceftriaxone non-susceptible pneumococci in South Korea: Long-term care facilities as a potential reservoir. PLoS One 2019;14:e0210520. [PMID: 30699137 DOI: 10.1371/journal.pone.0210520] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
24 Shekhar S, Åmdal HA, Petersen FC. Vaccination With the Commensal Streptococcus mitis Expressing Pneumococcal Serotype 5 Capsule Elicits IgG/IgA and Th17 Responses Against Streptococcus pneumoniae. Front Immunol 2021;12:676488. [PMID: 33953733 DOI: 10.3389/fimmu.2021.676488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Plotkin SA. Updates on immunologic correlates of vaccine-induced protection. Vaccine 2020;38:2250-7. [PMID: 31767462 DOI: 10.1016/j.vaccine.2019.10.046] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 12.7] [Reference Citation Analysis]
26 Bilgin GM, Lokuge K, Glass K. Modelling the impact of maternal pneumococcal vaccination on infant pneumococcal disease in low-income settings. Vaccine 2022;40:4128-34. [PMID: 35667913 DOI: 10.1016/j.vaccine.2022.05.066] [Reference Citation Analysis]
27 Sohail I, Ghosh S, Mukundan S, Zelewski S, Khan MN. Role of Inflammatory Risk Factors in the Pathogenesis of Streptococcus pneumoniae. Front Immunol 2018;9:2275. [PMID: 30333833 DOI: 10.3389/fimmu.2018.02275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
28 Feldman C, Anderson R. Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections. F1000Res 2020;9:F1000 Faculty Rev-338. [PMID: 32411353 DOI: 10.12688/f1000research.22341.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
29 Faingelernt Y, Dagan R, Givon-lavi N, Ben-shimol S, Bar-ziv J, Greenberg D. Nasopharyngeal Carriage of Invasive Pneumococcal Serotypes During Childhood Community-Acquired Alveolar Pneumonia Is Associated With Specific Clinical Presentation. The Journal of Infectious Diseases 2019. [DOI: 10.1093/infdis/jiz513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
30 Connor MG, Camarasa TMN, Patey E, Rasid O, Barrio L, Weight CM, Miller DP, Heyderman RS, Lamont RJ, Enninga J, Hamon MA. The histone demethylase KDM6B fine-tunes the host response to Streptococcus pneumoniae. Nat Microbiol 2021;6:257-69. [PMID: 33349663 DOI: 10.1038/s41564-020-00805-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Converso TR, Assoni L, André GO, Darrieux M, Leite LCC. The long search for a serotype independent pneumococcal vaccine. Expert Rev Vaccines 2020;19:57-70. [PMID: 31903805 DOI: 10.1080/14760584.2020.1711055] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
32 Murad C, Dunne EM, Sudigdoadi S, Fadlyana E, Tarigan R, Pell CL, Watts E, Nguyen CD, Satzke C, Hinds J, Dewi MM, Dhamayanti M, Sekarwana N, Rusmil K, Mulholland EK, Kartasasmita C. Pneumococcal carriage, density, and co-colonization dynamics: A longitudinal study in Indonesian infants. International Journal of Infectious Diseases 2019;86:73-81. [DOI: 10.1016/j.ijid.2019.06.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
33 Middleton DR, Paschall AV, Duke JA, Avci FY. Enzymatic Hydrolysis of Pneumococcal Capsular Polysaccharide Renders the Bacterium Vulnerable to Host Defense. Infect Immun 2018;86:e00316-18. [PMID: 29866907 DOI: 10.1128/IAI.00316-18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
34 Severiche-Bueno DF, Severiche-Bueno DF, Bastidas A, Caceres EL, Silva E, Lozada J, Gomez S, Vargas H, Viasus D, Reyes LF. Burden of invasive pneumococcal disease (IPD) over a 10-year period in Bogotá, Colombia. Int J Infect Dis 2021;105:32-9. [PMID: 33582374 DOI: 10.1016/j.ijid.2021.02.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
35 Kaneko F, Kono M, Sunose H, Hotomi M. Neutrophil infiltration in co-housed littermates plays a key role in nasal transmission of Streptococcus pneumoniae in an infant mouse model. Folia Microbiol (Praha) 2021. [PMID: 34480257 DOI: 10.1007/s12223-021-00901-0] [Reference Citation Analysis]
36 Huang CC, Chang TH, Lee CY, Wu PW, Chen CL, Lee TJ, Liou ML, Chiu CH. Tissue microbiota in nasopharyngeal adenoid and its association with pneumococcal carriage. Microb Pathog 2021;157:104999. [PMID: 34044045 DOI: 10.1016/j.micpath.2021.104999] [Reference Citation Analysis]
37 Arokiaraj MC. Possibilities for Coronavirus (COVID 19) – The Perspectives. SSRN Journal. [DOI: 10.2139/ssrn.3562102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Davies NG, Flasche S, Jit M, Atkins KE. Modeling the effect of vaccination on selection for antibiotic resistance in Streptococcus pneumonia e. Sci Transl Med 2021;13:eaaz8690. [PMID: 34380772 DOI: 10.1126/scitranslmed.aaz8690] [Reference Citation Analysis]
39 Mussi-Pinhata MM, Ward S, Laimon L, Pelton SI, Canniff J, Golner A, Bone F, Newton L, Muresan P, Fenton T, Johnson MJ, João EC, Santos BR, Pilotto JH, Oliveira RH, Pinto JA, Dal Bó AGBL, Kreitchmann R, Chakhtoura N, Duarte G, Weinberg A; NICHD P1091 study team. Effect of Maternal Vaccination of PCV-10, PPV-23 or Placebo on the Immunogenicity of PCV-10 in HIV-exposed Uninfected Infants: A Randomized Clinical Trial. Clin Infect Dis 2022:ciac026. [PMID: 35037049 DOI: 10.1093/cid/ciac026] [Reference Citation Analysis]
40 Thindwa D, Pinsent A, Ojal J, Gallagher KE, French N, Flasche S. Vaccine strategies to reduce the burden of pneumococcal disease in HIV-infected adults in Africa. Expert Rev Vaccines 2020;19:1085-92. [PMID: 33269987 DOI: 10.1080/14760584.2020.1843435] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]